We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+3.47%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+336.66%
AUM
$405B
AUM Growth
+$3.26B
Cap. Flow
-$4.73B
Cap. Flow %
-1.17%
Top 10 Hldgs %
17.59%
Holding
10,501
New
1,227
Increased
3,693
Reduced
4,131
Closed
1,043

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$1.12B
2
AAPL icon
Apple
AAPL
+$1.08B
3
MSFT icon
Microsoft
MSFT
+$1.05B
4
NKE icon
Nike
NKE
+$1.03B
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$821M

Sector Composition

Rank Sector Weight
1 Technology 17.8%
2 Financials 8.25%
3 Healthcare 6.4%
4 Consumer Discretionary 5.85%
5 Communication Services 4.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MRAI
10426
DELISTED
Marpai, Inc. Class A Common Stock
MRAI
-9,578
Closed -$23.4K
BSFC
10427
DELISTED
Blue Star Foods Corp. Common Stock
BSFC
-4,607
Closed -$21.2K
FNCH
10428
DELISTED
Finch Therapeutics Group, Inc. Common Stock
FNCH
-110
Closed -$286
ACOR
10429
DELISTED
Acorda Therapeutics
ACOR
-106
Closed -$1.4K
LABP
10430
DELISTED
Landos Biopharma, Inc. Common Stock
LABP
-4,084
Closed -$87.7K
SECO
10431
DELISTED
Secoo Holding Limited ADR
SECO
-143
Closed -$59
AMPE
10432
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
-1,246
Closed -$1.15K
XELA
10433
DELISTED
Exela Technologies, Inc. Common Stock
XELA
-4,191
Closed -$13.6K
LEJU
10434
DELISTED
Leju Holdings Limited American Depositary Shares, each representing ten (10) Ordinary Shares
LEJU
-1
Closed -$1
CHGX
10435
DELISTED
AXS Change Finance ESG ETF
CHGX
-3
Closed -$110
KLDW
10436
DELISTED
Knowledge Leaders Developed World ETF
KLDW
-30
Closed -$1.34K
MACK
10437
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
-12,442
Closed -$184K
EGLE
10438
DELISTED
Eagle Bulk Shipping Inc.
EGLE
-21,983
Closed -$1.37M
VSTO
10439
PUT
DELISTED
Vista Outdoor Inc.
VSTO
-421,700
Closed -$13.8M
AMNB
10440
DELISTED
American National Bankshares Inc
AMNB
-8,170
Closed -$390K
AILEW
10441
DELISTED
iLearningEngines, Inc. Warrant
AILEW
-3
Closed -$1
MAGQ
10442
DELISTED
Roundhill Daily Inverse Magnificent Seven ETF
MAGQ
-49
Closed -$1.18K
PUCKU
10443
DELISTED
Goal Acquisitions Corp. Unit
PUCKU
-5
Closed -$47
AIBBU
10444
DELISTED
AIB Acquisition Corp Unit
AIBBU
-1
Closed -$10
FHLTU
10445
DELISTED
Future Health ESG Corp. Unit
FHLTU
-24
Closed -$229
OSAAW
10446
DELISTED
ProSomnus, Inc. Warrant
OSAAW
-500
Closed -$10
RACY
10447
DELISTED
Relativity Acquisition Corp. Class A Common Stock
RACY
-548
Closed -$6.73K
QIWI
10448
DELISTED
QIWI PLC
QIWI
$0 ﹤0.01%
214
-2,686
-93%
CWBC
10449
DELISTED
Community West BanCshares
CWBC
-2,186
Closed -$33.8K
INBX
10450
DELISTED
Inhibrx, Inc. Common Stock
INBX
-445,197
Closed -$15.6M

Similar funds

UBS Group's Q2 2024 Portfolio in Review

As of Q2 2024, UBS Group held 10,501 positions worth $405B, up 0.81% from $402B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

UBS Group's Q2 2024 filing shows 1,227 new, 3,693 increased, 4,131 reduced and 1,043 closed positions. Its largest new stake was SLB Ltd: 10,925,731 shares worth $515M. The largest sale was BioMarin Pharmaceuticals, an estimated $389M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.

  • UBS Group's largest Q2 2024 buy was SLB Ltd: 10,925,731 shares worth $515M.
  • UBS Group added most to NVIDIA in Q2 2024, an estimated $1.12B increase.
  • UBS Group's biggest Q2 2024 reduction was BioMarin Pharmaceuticals, cutting an estimated $389M.
  • UBS Group fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $263M.
  • UBS Group's ten largest holdings make up 18% of its $405B portfolio in Q2 2024.
  • UBS Group opened 1,227 new positions and closed 1,043 in Q2 2024.
  • UBS Group's portfolio value rose 0.81% quarter-over-quarter to $405B.

Based on UBS Group's 13F filing for Q2 2024, filed 14 Aug 2024.